AU729120B2

AU729120B2 - Underarm compositions

Info

Publication number: AU729120B2
Application number: AU72851/96A
Authority: AU
Inventors: Martinho Correia; Desmond Bernard Hagan
Original assignee: Unilever PLC
Current assignee: Unilever PLC
Priority date: 1995-10-27
Filing date: 1996-10-04
Publication date: 2001-01-25
Anticipated expiration: 2016-10-04
Also published as: GB9521991D0; HUP9802997A2; AU7285196A; HUP9802997A3; PL327241A1; CA2234930A1; JP2000500434A; CA2234930C; BR9611179A; WO1997016161A1; MX9803174A; RU2189219C2; EP0869770A1; AR004115A1; ZA968249B

Description

WO 97/16161 PCT/EP96/04318 1 UNDERARM COMPOSITIONS The invention relates to novel cream underarm compositions which contain a structuring wax material. More particularly, the invention concerns antiperspirant and deodorant compositions for topical application to the human skin, containing structuring wax, a clay material and a masking oil.

It is known for underarm compositions for topical application to contain non-volatile silicone fluids such as polyorganosiloxanes which impart emolliency to the composition and can provide a masking effect to conceal solids present in the composition. Examples of such solids include antiperspirant actives. The efficacy of the composition is not seriously affected by the presence of the non-volatile silicone. An example of such compositions is to be found in EP 28853 (The Procter Gamble Company).

It is also known to include certain categories of alkyl siloxane waxes in underarm compositions. EP 549223 (Dow Corning) describes stick, roll on and spray underarm compositions containing certain long chain alkyl silicone waxes. The waxes are alleged to provide the formulations with desirable characteristics such as improved hardness, reduced whitening, improved skin feel and compatibility with other ingredients.

Our co-pending British Patent Application Number 9506039.8 describes the use of alkyl ester siloxane waxes to improve the sensory properties such as skin feel of underarm compositions.

The abovementioned formulations of the prior art describe suspension compositions which are generally preferred to the 23-11-00; 4:41PM;DAVIES COLLISON CAVE ;612 92621080 7/ 14 -2already known emulsion compositions which have been found to produce undesirable sensations on the skin such as a sticky or wet feeling. The suspending agent facilitates the efficient suspension of powder materials such as antiperspirant actives in the composition to enhance efficacy and stability of the composition on storage.

However, many suspending agents of the prior'art, whilst improving skin feel in some respects (eg. reducing the wet sensation) impart other undesirable sensations to the skin such as grittiness and can also result in visible deposits on the skin and fabrics.

In an attempt to overcome this problem EP135315 (The Mennen *o .0 15 Company) describes a clay free antiperspirant product containing a volatile silicone and a gelling agent.

However, the omission of the clay suspending agent can result in a product which is still unstable at high eprtue n ve rlne prosad hc a teprtrs n vrprlneoerosadwhc•a 20 lowered viscosity which can be undesirable in creamformulat ions.

An object of the invention is to overcome the disadvantages 0 0: of the formulations of the prior art.

o According to the invention there is provided a substantially anhydrous underarm cream composition suitable for topical application to the human skin, comprising an antiperspirant and/or deodorant agent, 0.5% to 3% by weight of a clay suspending or thickening agent, 5.0% to 25% by weight of a non-volatile masking agent, 3 to 20% by weight of a structuring wax having a melting point of at least 45 9 C, said wax including a wax selected from the group consisting of alkylmethyl siloxane waxes and alkylester waxes, and 20 to 90% volatile carrier fluid, obtainable by shearing together 23/11 '00 THU 16:45 [TX/RX NO 6952] J3347 2a at least the antiperspirant and/or deodorant agejit, the clay, the masking agent, the carrier fluid and the wax above the melting point of said wax.

4 4* 4 4 .4 4 4*44 44.4 a 4 *44**4 4 4* 44 44 4 J3347 -3 Preferably, the underarm cream composition comprises 1% to 2% by weight of clay. Suitably, the clay is selected from the group comprising bentonites, smectites, saponites, reacted variants thereof and mixtures thereof.

Preferably, the underarm composition comprises 5% to 15% by weight structuring wax and the structuring wax is selected from the group comprising alkyl methyl siloxane waxes, alkyl ester siloxane waxes, and mixtures with insect and animal waxes, fatty acids, fatty alcohols, fatty acid esters and fatty acid amides.

Preferably, the alkyl methyl siloxane wax is a wax having a general formula I: R (SiMe2-O-) xSiMe2R wherein R is a C16-C40 alkyl group, X is 10 to 50, and Me is a CH3 group and the average terminal alkyl chain length is at S* 20 least Preferably R is a C25-C40 alkyl group.

Alternatively, the alkyl ester siloxane wax is a wax of 25 general formula II: (Me3Si) 0 (SiMe2O)aSi (Me) (CH2) b-O-COR (SiMe3) Swherein a is an integer from 0 to 2; b is an integer from 2 to 4; Me is CH3; R is a straight or branched chain alkyl from CioH21 to C3oH61.

Suitably, R is C19H39, a is 1 and b is 3.

J3347 -4 Preferably, the non-volatile masking agent is a non-volatile masking oil selected from the group comprising non-volatile silicones and polyolefins or mixtures thereof. More preferably, the polyolefin is polydecene.

Suitably, the volatile carrier fluid is a volatile silicone.

Advantageously, the antiperspirant agent is an inorganic and/or organic source of aluminum and zirconium or a mixture thereof.

In an alternative embodiment the invention provides a substantially anhydrous cream antiperspirant composition -comprising 5 to 30% by weight antiperspirant agent, 0.5% to 3% by weight of a clay suspending or thickening agent, 5% to 25% by weight of a non-volatile masking agent, 3% to 20% by weight of a structuring wax having a melting point of at least 45 0 C and 20 to 86.5% volatile carrier fluid, obtainable by shearing together at least the antiperspirant, the masking agent, the carrier fluid and the clay and the 20 wax at a temperature equal to or above the melting point of said wax.

S Generally, creams are defined in terms of cone penetration values. A typical cream can be described as having a cone 25 penetration value of between approximately 10mm and oo where the cone has a diameter of 16.5mm and a weight of 102.5g.

Surprisingly, it has now been found that by combining a structuring wax having specified melting point characteristics with a clay suspending agent and a nonvolatile masking agent and subjecting the mixture to shear above the melting point an underarm composition which is stable for long periods and at high temperatures is J3347 4a obtained. However, the composition does not exhibit any of the undesirable characteristics such as poor skin feel and *o WO 97/16161 PCT/EP96/04318 deposition previously associated with clay containing underarm compositions.

Suitable clays are hectorires and montmorillionites including bentonites, smectites, saponites and reacted variants thereof. A preferred bentonite is Bentone 38 available from NL Industries. A single clay or a blend of clays can be used.

Typically used antiperspirant salts include inorganic and organic salts of aluminium and zirconium and mixtures thereof. Particularly preferred are the aluminium/zirconium salts of aluminium halides, aluminium hydroxyhalides, aluminium zirconium salts and mixtures thereof. Particularly preferred antiperspirant salts include activated aluminium chlorohydrate compounds as described in EP6739 (Unilever NV et al). Further antiperspirant actives are described in EP 28853. The contents of both these applications are incorporated herein by reference.

Any effective deodorant composition known in the art is suitable for incorporation into the composition e.g. sodium bicarbonate, zinc ricinoleate, other inorganic salts, short chain monohydric alcohols, polyhydric alcohols or compounds such as triclosan. The deodorants can be utilised alone or in conjunction with the antiperspirant active component where compatible.

The carrier fluid suitably comprises a volatile silicone material. Examples of such materials are cyclic or linear polydimethylsiloxanes. Preferred cyclic polydimethylsiloxanes have from 3 7 silicone atoms and a viscosity less than 10 mm 2 s' 1 (cSt) at 25 0 C. Preferred linear polydimethylsiloxanes have from 3 9 silicone atoms and a viscosity of less than 5 mm 2 s at 25 0 C. Preferred WO 97/16161 PCT/EP96/04318 6 polydimethylsiloxanes are available from Dow Corning Corporation as Dow Corning 344 and 345. Preferably, if used in the composition, the volatile silicone is present at a level of 30 to 60% by weight, more preferably 40 to 60% by weight.

The non-volatile masking agent is also present in the formulation and preferably comprises a hydrocarbon polymer such as poly olefins.

The poly olefins are suitably hydrocarbon polymers, with the preferred ones being liquid at room temperature 21 0

C).

It is also highly preferred that the poly olefin in the composition has a relatively low viscosity. Preferably, the viscosity of the poly olefin hydrocarbon masking agent is less than about 40 cSt at 40 0 C, more preferably less than about 30 cSt at 40 0

C.

Preferably, the poly olefin comprises a poly alpha olefin.

Preferred poly alpha olefins for use in compositions according to the invention are polydecenes, for example the Silkflo range of polydecenes, manufactured by Albermarle Corporation. Other preferred poly olefins for use in compositions according to the invention include polybutene, which is commercially available under the trade name Panalene L14E from Amoco, and polyisobutene, which can be obtained from Prespere under the trade name Permethyl.

As such, preferred poly olefins for use in compositions according to the invention may have monomer chain lengths in the region of 3-15 carbon atoms. Preferred poly olefin blends which are commercially available may conveniently contain a blend of various polymers, including dimers, trimers, and so on. Preferred materials for use in compositions according to the invention include Silkflo WO 97/16161 PCT/EP96/04318 7 362NF, Silkflo 364NF, and Silkflo 366NF, available from Albermarle Corporation.

When used in compositions according to the invention, the poly olefin hydrocarbons described help to confer to the composition surprisingly good sensory properties, including a surprising lack of greasiness after application, and where the composition is an antiperspirant composition, provide an enhanced degree of masking of any whiteness that may be left by the antiperspirant salt in the composition.

An advantage of using the poly olefin hydrocarbons is that they have been found not to interfere with the efficacy of any antiperspirant active salt in the composition to any major degree.

The non-volatile masking oil which can function as an emollient can also be a non-volatile silicone. The nonvolatile silicone may be a polyalkyl siloxane, a polyalkaryl siloxane or a polyether siloxane copolymer. Preferred polyalkysiloxanes have viscosities ranging from 10 to 100,000 nm2s (cSt) at 25 0 C. Such siloxanes are available from the Dow Corning Corporation as the Dow Corning 200 series.

Suitable polyalkaryl siloxanes are the polymethylphenylsiloxanes having viscosities of 15 to 2 s (cSt) at 25 0 C. These siloxanes are available as the Dow Corning 556 fluid.

A suitable polyether siloxane is dimethyl polyoxyalkylene ether copolymer having a approximate viscosity of 1200 to 1500 mm 2 s (cSt) at 25 0 C e.g. a polysiloxane ethylene glycol ether copolymer.

Preferred structuring waxes are the alkyl methylsiloxanes.

WO 97/16161 PCT/EP96/04318 8 Suitable alkyl methylsiloxanes include those having the general formula R (SiMe 2 x SiMe 2

R

where R C16 to x 10-50 Me CH 3 The structuring waxes have been found to exhibit a significant masking effect on the formulations to conceal deposition of actives and suspending agents. The alkylmethylsiloxane wax preferably has a melting point of greater than 45 0

C.

Preferably, the alkylmethylsiloxane wax is made up of C16 to alkyl groups, more preferably C25 to Generally, such waxes will be made up of a blend of alkyl group chain lengths with the characteristics of the wax and hence its structuring effect being determined by the blend of chain lengths utilised.

The waxes selected having terminal long alkyl chains are particularly effective at structuring the composition.

Pendant C30 and upwards species and C16 to C18 terminal alkyl waxes sometimes result in excessively soft solids which may fail to keep a stable structure following heat storage which results in an excessively thin composition. Similar difficulties are experienced when the average terminal alkyl chain length is below A preferred alkylmethylsiloxane wax is known as GE wax SF1642 available from the General Electric Company in which the main alkyl species are C30, C32 and C34 with minor amounts of C26 and C28.

WO 97/16161 PCT/EP96/04318 9 The structuring wax can also be an alkyl ester siloxane wax of general formula (II): (Me 3 Si)O(SiMe 2 O),Si(Me) (CH,)b-O-COR(SiMe 3 where a is an integer from 0 to 2 b is an integer from 2 to 4 Me is CH 3 R is a straight or branched chain alkyl from

C

1 oH 21 to C 30

H

61 Suitably, R is a straight chain alkyl C 19

H

39 In addition, a is suitably 1 and b is suitably 3.

The wax used in compositions according to the invention is an alkyl ester silicone wax. The inclusion of this wax in the formulation may impart some emolliency to the composition.

Accordingly, it is possible to do without, or reduce, the amount of emollient materials, such as volatile or nonvolatile silicones, which are conventionally included in such compositions.

A particularly preferred alkyl ester silicone wax for use in compositions according to the invention is a behenic acid silicone wax, which in general structure (II) has a value for a of 1 and for b of 3, and in addition has R as C 19

,H

9 Such a wax is available from Rhone Poulenc under the tradename Mirasil-B 71649 wax.

Other structurant waxy materials which may also be employed in accordance with the present invention include high and low melting point waxes, gums, resins, polymers, starches and elastomers. High melting point waxes include insect and animal waxes such as beeswax and spermaceti; vegetable waxes such as carnauba, candelilla, Ouricury, Japan wax, WO 97/16161 PCT/EP96/04318 Douglas-fir bark wax, rice-bran wax, castor wax and bayberry wax; mineral waxes such as montan wax, peat wax, ozokerite and ceresin; petroleum waxes such as paraffin wax; synthetic waxes such as Fischer-Tropsch waxes, polyethylene waxes, chemically modified hydrocarbon waxes and substituted amide waxes. Examples of low melting point waxes include fatty acids, fatty alcohols, fatty acid esters and fatty acid amides having carbon chains of 3 to 30 carbon atoms.

Particularly preferred low melting point waxes include stearyl alcohol, cetyl alcohol, myristyl alcohol and palmitic acid.

The wax structurant can be a single wax or blend of the aforementioned waxes selected to provide the desired melting point and skin feel characteristics. For instance, a combination of 6% SF1642 and 5% Castorwax MP80 is particularly effective and results in a wax structurant which shears at approximately 45 0

C.

WO 97/16161 PCT/EP96/04318 Example 1 An anhydrous antiperspirant cream was produced having the following formulation: Ingredient AZAG (Powder) Castorwax MP80 GE SF1642 (1229-425) Function Antiperspirant Structurant Silicone Wax Deposit Masker Bentone Structurant Volatile Silicone Carrier Fluid Non-Volatile Hydrocarbon Deposit Masker (Albemarle Silkflo 364NF) Talc (Suprafino) Aid Dry Skin-Feel Fragrance 24.0 45.0 10.0 The cream was made by using the following four stages: Stage 1: 10.0% Silkflo 364NF, 45.0% Volatile Silicon DC345 Add Silkflo to Volatile Silicone, start stirrer to half speed and heat to 66 0

C.

Stage 2: 1.0% Bentone 38, 8.0% Suprafino Talc, 24.0% AZAG Powder Draw in powders and mix for 5 minutes. After addition is complete, reheat to 66 0

C.

Stage 3: 5.0% Castorwax MP80, 6.0% GE Wax SF1642 WO 97/16161 PCT/EP96/04318 12 Premelt waxes at 80 0 C and then add to main vessel with stirring at full speed.

Stage 4: 1.0% Fragrance Add perfume and shear for 5 minutes at 68-70 0

C.

Comparative Example: The above cream in Example 1 was manufactured with the omission of Bentone. The Bentone was replaced by 1% volatile silicone carrier fluid and manufactured in the same way.

Comparative Data (Sensory): panellists applied 0.lg of a cream to the backs of their hands, rubbed for 5 seconds and then made tactile assessments of dryness and greasiness. 14/20 selected the Bentonecontaining cream as the drier (significantdifference at >94% confidence) over the non-Bentone control cream.

For greasiness, 13/20 selected the Bentone-containing cream as less greasy than the non-Bentone control (significant difference at >86% confidence).

The above results with regard to greasiness and dryness are summarised in Table I.

Comparative Data (Processing): In terms of processing benefit, the Bentone containing composition was more viscous than the non-Bentone equivalent.

For instance, the Bentone containing composition when processed at 68 0 C, sheared for 10 minutes and then filled at WO 97/16161 PCT/EP96/04318 13 degoC a composition having a viscosity ranging from 235,000 to 240,000 cps was obtained.

The identical non-Bentone composition had a viscosity of 220,000 cps.

Moreover, when the product was processed and filled at 68 0

C,

and mixed as above for 10 minutes, then the Bentone composition had a viscosity of 472,000 cps whereas the Bentone free composition had a viscosity of 360,000 cps.

Example 2 An anhydrous antiperspirant cream having the following composition was prepared as described in Example 1: Ingredient %t AZAG (powder) 24.0 Castorwax MP80 GE SF1642 Bentone Volatile Silicone 43.0 Silkflo 364NF 14.0 Talc Fragrance Rheolocv The rheology of the formulation of example 2 was examined to demonstrate the stability characteristics of the composition when processed at various temperatures.

A Carri-Med Controlled Stress Rheometer CSL100 instrument was used. A vane/cup measuring system was employed with a mesh interior fitted to the cup to ensure prevention of wall slip.

WO 97/16161 PCT/EP96/04318 14 Experiments were carried out at 25 0 C unless otherwise stated.

Equilibrium flow experiments were conducted on fresh samples to obtain the exact flow properties of the sample. The sample was allowed to equilibrate at a fixed temperature (25 0 C) for one hour before measuring to ensure no temperature gradient.

The data produced resulted in an equilibrium viscosity figure (Pa.s) which occurs under low shear stress and the point at which the sample catastrophically fails. The lower the equilibrium viscosity figure the more unstable the sample.

Results Figure 1 shows the rheological properties of the composition of Example 2 when processed at 29 0 C, 45 0 C and 600C. As shown in the Figure low temperatures did not result in a stable structured product. Low equilibrium viscosity figures are usually an indication that the product will show leakage of carrier fluid.

As shown in the Figure the composition of Example 2 when processed at 290C resulted in an unstable composition while the samples processed at 450C and 600C were significantly more stable and hence less disposed towards carrier leakage.

The following examples describe compositions produced according to the method described for Example 1 in which a variety of waxes, clays, and emollients are used.

WO 97/16161 PCT/EP96/04318 Examole 3 Inaredient wt Aluminium Zirconium Tetrachlorohydrex Glycine Complex 25.0 Bentone 38 1 Trihydroxy stearin Isopropyl palmitate 11.0 Cyclomethicone DC345 60.0 Polyethylene ('Smectite clay mineral lattice containing organic cations, from Steetley/NL Industries Examole 4 Ingredient wt Aluminium Zirconium Octachlorohydrex Glycine Complex 22.00 Perchem 462 montmorillonite clay (from Percham) 1.25 Cyclomethicone DC245 40.10 Behenyl beeswaxate (from Koster Keunen) 6.00 Mirasil B (from Rhone Poulenc) 2.00 Polyethylene 6.65 Panalane L-14E polybutene (Amoco) 22.00 Example Inaredient wt Aluminium Zirconium Pentachlorohydrex Glycine Complex 25.0 Bentone Gel IPM 12 Cerit SH hydrogenated castor oil (Ceralit) Finsolv TN (C12-15 Alcohols Benzoate from Finetex) 18.0 Volatile Silicone DC244 44.5 Talc WO 97/16161 PCT/EP96/04318 16 organically modified smectite clay gelled in isopropyl myristate, from Steetley/NL Industries Example 6 Ingredient wt Aluminium Zirconium Trichlorohydrex Glycine Complex 18.0 Bentone Gel SIL' 3 Dimethicone DC200 Fluid 350cs 25.0 Candelilla Wax C24/C28 Alkyl Dimethicone Wax Volatile Silicone DC344 43.5 3 organically modified smectite clay gelled in silicone, from Steetley/NL industries Example 7 Ingredient wt Aluminium Zirconium Tetrachlorohydrex Glycine Complex 15.0 Ozokerite Wax Isopropyl myristate 20.0 Cyclomethicone DC345 50.0 Veegum D 4 Talc refined smectite clay from R T Vanderbilt WO097/161 61 -PCTIEP96/0431 8 17 Aluminium Zirconium Pentachiorohydrex Glycine Complex 26.0 Bentone EWI' Thixcin R1 6 1 Cyclomethicone 52.5 Dimethicone DC200 Fluid 1O0cs C30+ Alkyl dimethicone Polyethylene powdered smectite clay from Steetley 6hydrogenated castor oil from Rheox Examole 9 Inarediet %w Aluminium Chlorohydrate ultrafine powder 25.0 Nectabrite AW montmorillonite (from American colloid) 0.8 Stearyl alcohol Cetyl alcohol Alkyl dimethicone Cyclomethicone 58.9 Dry Flo Fragrance 0.8 WO 97/16161 PCT/EP96/04318 18 Example Ingredient Wt Aluminium Zirconium Trichlorohydrex Glycine Complex 25.0 Bentone 38 (Steetley/NL Industries) Castorwax MP80( 7 Waxenol 822 1 Diisopropyl dilinoleate (Pripure 3786 DIPD) Cylcomethicone 59.5 7 hydrogenated castor oil '8 Eicosanol behenate from Caschem Throughout this specification and the claims which follow, unless the context requires otherwise, the word "comprise", or variations such as "comprises" or "comprising", will be understood to imply the inclusion of a stated integer or step or group of integers or steps but not the exclusion of any other integer or step or group of integers or steps.

o*oo*

Claims

23-11-00; 4:41PM;DAVIES COLLISON CAVE ;612 92621080 8/ 14 19 The Claims defining the invention are as follows: 1. A substantially anhydrous underarm cream composition suitable for topical application to the human skin, comprising an antiperspirant and/or deodorant agent, to 3% by weight of a clay suspending or thickening agent, 5.0% to 25% by weight of a non-volatile masking oil, 3 to 20% by weight of a structuring wax having a melting point of at least 45"C said wax including a wax 10 selected from the group consisting of alkylmethyl S.siloxane waxes and alkyl ester siloxane waxes, and 20 to 90% volatile carrier fluid, obtainable by shearing together at least the antiperspirant and/or deodorant agent, the clay, the masking oil, the carrier fluid and 15 the wax above the melting point of said wax. *99 2. An underarm composition as claimed in claim 2 characterised in that it comprises 1% to 2% by weight of clay- "o 3. An underarm composition as claimed in claim 1 or claim 2 characterised in that the clay is selected from the group comprising bentonites, smectites, saponites, reacted variants thereof and mixtures thereof. 4. An underarm composition as claimed in any of claims 1 to 3 characterised in that it comprises 5% to 15% by weight structuring wax. 5. An underarm composition as claimed in any of claims 1 to 4 characterised in that the structuring wax also includes a wax selected from the group comprising insect and animal waxes, fatty acids, fatty alcohols, fatty acid esters and fatty acid amides and mixtures thereof. 23/11 '00 THU 16:45 [TX/RX NO 6952] 23-11-00; 4:41PM:DAVIES COLLISON CAVE;62 2200# /4 ;612 92621080 9/ 14 6. An underarm composition as claimied in a'ny. of claims 1 to characterised in that the alkylmethyrlsiloxane wax is a wax having the general formula I'; S R- (SiMe2-O-) XSiMe2R wherein R is a C16-C40 alkyl group, X is 10 to 50, and Me is a CH3 group and the average terminal alk3 1 chain length is at least 7. An underarm composition as claimed in claim 6 characterised in that R is a C25 to C40 alkyl group. An underarm composition as claimed in any of claims 1 to 5 characterised in that the alkyl eater siloxane wax is a wax of general formula II: (Me3Si) 0 (SiMe2O) &Si (Me) (CHb) h-O-COR (SiMe3) 20 wherein a is an integer from 0 to 2; b is an integer from 2 to 4; Me i S CH3; is a straight or branched chairi alkyl.fo CilH2 to C301461 9. An underarm composition as claimed in claim 8 characterised in that R is Cz9H39,- a -is 1 and b is 3. An underarm composition as claimed in any of claims 1 to 9 characterised in that the non-volatile masking oil selected from the group comprising non-volatile silicones and polyolef ins or mixtures thereof. NT 23/11 '00 THU 16:45 [TX/RX NO 69521 23-11-00; 4:41PM;DAVIES COLLISON CAVE ;612 92621080 10/ 14 21 12. An underarm composition as claimed in any of claims 1 to 11 characterised in that the volatile carrier fluid is a volatile silicone. 13. An underarm composition as claimed in any of claims 1 to 12 characterised in that the antiperspirant agent is an inorganic and/or organic salt of aluminium and zirconium or a mixture thereof. 14. A substantially anhydrous cream antiperspirant composition comprising 5 to 30% by weight antiperspirant agent, 0.5% to 3% by weight of a clay suspending or thickening agent, 5% to 25% by weight of a non-volatile masking oil, 3% to 20% by weight of a structuring wax S 15 having a melting point of at least 45 0 C said wax including a wax selected form the group consisting of alkylmethyl siloxane waxes and alkyl ester siloxane waxes, and 20 to 86.5% volatile carrier fluid, obtainable by shearing together at least the antiperspirant, the 20 masking oil, the carrier fluid and the clay and the wax at a temperature equal to or above the melting point of said wax. 15. An underarm composition as hereinbefore described with reference to the examples. DATED THIS 23rd day of November, 2000. UNILEVER PLC By Its Patent Attorneys DAVIES COLLISON CAVE 23/11 THU 16:45 [TX/RX NO 6952 23/11 '00 THU 16:45 2 [TX/RX NO 6952]